| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash flow used in financing activities | -565 | -565 |
| Foreign currency impact | 0 | 0 |
| Increase in cash and cash equivalents | 8,598 | 10,766 |
| Cash and cash equivalents at beginning of period | 90,928 | - |
| Cash and cash equivalents at end of period | 99,526 | - |
MEDIFAST INC (MED)
MEDIFAST INC (MED)